These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31254047)

  • 21. A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis.
    Tutolo M; Ammirati E; Castagna G; Klockaerts K; Plancke H; Ost D; Van der Aa F; De Ridder D
    Int Braz J Urol; 2017; 43(1):134-141. PubMed ID: 28124536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with treatment outcomes after intravesical hyaluronic acid therapy in women with refractory interstitial cystitis: A prospective, multicenter study.
    Tsai CP; Yang JM; Liang SJ; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Hung MJ
    J Chin Med Assoc; 2021 Apr; 84(4):418-422. PubMed ID: 33784267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium hyaluronic acid-chondroitin sulphate (Ialuril®).
    Costantini E; Lazzeri M; Pistolesi D; Del Zingaro M; Frumenzio E; Boni A; Pietropaolo A; Fragalà E; Porena M
    Urol Int; 2013; 91(1):81-8. PubMed ID: 23485915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravesical administration of combined hyaluronic acid and chondroitin sulfate can improve symptoms in patients with refractory bacillus Calmette-Guerin-induced chemical cystitis: Preliminary experience with one-year follow-up.
    Imperatore V; Creta M; Di Meo S; Buonopane R; Longo N; Fusco F; Spirito L; Imbimbo C; Mirone V
    Arch Ital Urol Androl; 2018 Mar; 90(1):11-14. PubMed ID: 29633792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of onabotulinum toxin-A injection on sexual function in women with refractory interstitial cystitis/bladder pain syndrome: A prospective study.
    Karaburun MC; Kubilay E; Öztuna D; Gökçe Mİ; Süer E; Gülpınar Ö
    Low Urin Tract Symptoms; 2024 Mar; 16(2):e12511. PubMed ID: 38527461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
    Lai MC; Kuo YC; Kuo HC
    Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study.
    De Vita D; Giordano S
    Int Urogynecol J; 2012 Dec; 23(12):1707-13. PubMed ID: 22614285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study.
    Ciani O; Arendsen E; Romancik M; Lunik R; Costantini E; Di Biase M; Morgia G; Fragalà E; Roman T; Bernat M; Guazzoni G; Tarricone R; Lazzeri M
    BMJ Open; 2016 Mar; 6(3):e009669. PubMed ID: 27033958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronic acid-chondroitin sulfate: a potential factor to select pure stress urinary incontinence in patients with interstitial cystitis⁄painful bladder syndrome and mixed incontinence symptoms.
    Morelli M; Mocciaro R; Venturella R; Albano A; Sacchinelli A; Zullo F
    Minerva Ginecol; 2015 Apr; 67(2):121-5. PubMed ID: 25763801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral preparation of hyaluronic acid, chondroitin sulfate, N-acetylglucosamine, and vitamin C improves sexual and urinary symptoms in participants with recurrent urinary tract infections: a randomized crossover trial.
    Boeri L; De Lorenzis E; Lucignani G; Turetti M; Silvani C; Zanetti SP; Longo F; Albo G; Salonia A; Montanari E
    J Sex Med; 2024 Jun; 21(7):627-634. PubMed ID: 38721680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC).
    Meng E; Hsu YC; Chuang YC
    Low Urin Tract Symptoms; 2018 Jan; 10(1):3-11. PubMed ID: 29341502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis.
    De Vita D; Antell H; Giordano S
    Int Urogynecol J; 2013 Apr; 24(4):545-52. PubMed ID: 23129247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is intravesical instillation of hyaluronic acid and chondroitin sulfate useful in preventing recurrent bacterial cystitis? A multicenter case control analysis.
    Gugliotta G; Calagna G; Adile G; Polito S; Saitta S; Speciale P; Palomba S; Perino A; Granese R; Adile B
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):537-40. PubMed ID: 26522106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review.
    Han XM; Wu XH; Li B; Pan F; Li WC; Liu SL; Zeng FQ; Chen M
    Taiwan J Obstet Gynecol; 2015 Jun; 54(3):240-7. PubMed ID: 26166334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effectiveness and safety of intravesical instillation treatment of interstitial cystitis/bladder pain syndrome: a systematic review and network meta-analysis of randomized controlled trials.
    Liu S; Zhang C; Peng L; Lu Y; Luo D
    Int Urogynecol J; 2021 May; 32(5):1061-1071. PubMed ID: 32886173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of intravesical instillation with fulguration-hydrodistention on female interstitial cystitis].
    Xin P; Zhang H; Jiang ZM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):865-870. PubMed ID: 37807741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid.
    Jiang YH; Liu HT; Kuo HC
    PLoS One; 2014; 9(3):e91609. PubMed ID: 24614892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
    Lee CL; Kuo HC
    Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis.
    Lv YS; Zhou HL; Mao HP; Gao R; Wang YD; Xue XY
    Int Urogynecol J; 2012 Dec; 23(12):1715-20. PubMed ID: 22576327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.